A new derivatives reporting regime will commence in Australia in 2015. It will apply to Australian entities that hold an AFSL, and exempt foreign licensees (being offshore regulated parties that have the benefit of an exemption from the requirement to hold an AFSL), that have entered into OTC derivatives. Non-compliance could lead to substantial civil penalties.

Click here to view video.